Wilbert Bara

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

Grant Theron, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2013 · 444 citations

Public Health, Internal Medicine, Preventive Medicine +13

Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial

Greg Calligaro, Lynn S. Zijenah, Grant Theron et al. · The Lancet Infectious Diseases · 2017 · 89 citations

Public Health, Community Health, Internal Medicine +14

Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe

John Metcalfe, Salome Makumbirofa, Beauty Makamure et al. · Emerging infectious diseases · 2013 · 24 citations · Full text

Public Health, Infectious Diseases, Microbiology +16

Xpert<SUP>®</SUP> MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe

John Metcalfe, Salome Makumbirofa, Beauty Makamure et al. · The International Journal of Tuberculosis and Lung Disease · 2016 · 23 citations · Full text

Veterinary Medicine, Infectious Diseases, Antimicrobial Resistance +16

Mother-to-child transmission of HIV-1 and infant mortality in the first six months of life, in the era of Option B Plus combination antiretroviral therapy

Lynn S. Zijenah, Tsitsi Bandason, Wilbert Bara et al. · International Journal of Infectious Diseases · 2021 · 20 citations · Full text

Public Health, Infectious Diseases, Maternal Health +17